HMGB1 and Alzheimer disease: Further, interaction with intracellular Aβ [46] or treatment with an anti-HMGB1 antibody, which inhibits paracrine HMGB1-mediated induction of TRIAD in proximal neurons, significantly inhibited disease progression in AD mouse models [46,47,56].